Accolade Inc (STU:4NE1)
€ 3.42 0.12 (3.64%) Market Cap: 275.12 Mil Enterprise Value: 279.28 Mil PE Ratio: 0 PB Ratio: 0.70 GF Score: 61/100

Accolade Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 12:45PM GMT
Release Date Price: €33.85 (-2.45%)
Michael Aaron Cherny
BofA Securities, Research Division - Director

Good morning, everyone, and welcome to Day 2 -- or I guess, Day 3 at the BofA Virtual Healthcare Conference. I'm Mike Cherny, Healthcare Tech Distribution Analyst. Also with me today is Allen Lutz, who covers a number of our digital health names.

Much more importantly, though, we have the management team from Accolade, Raj Singh, CEO; Steve Barnes, CFO; and Todd Friedman, heads up IR as well. There is a slide deck attached to this website. We thought it'd be a bit more fun and interesting to do this in more of a fireside chat approach. But obviously, if anyone wants to catch up on that slide deck is -- and kind of go back up and get caught up on all the various different moves that Accolade's made recently, it's a definitely a good reference point.

Questions & Answers

Michael Aaron Cherny
BofA Securities, Research Division - Director

So with that, Raj, you just reported earnings last week. Obviously, just -- I think it was the week before, I'm losing track of time, but also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot